Framing Messages for Smoking Cessation With Bupropion - 6
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on May 08, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Tobacco Use Disorder
Intervention: Bupropion (Drug)
Phase: N/A
Status: No longer recruiting
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Stephanie O'Malley, Ph.D., Principal Investigator, Affiliation: Substance Abuse Treatment Unit
Summary
This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
Clinical Details
Official title:
Framing Messages for Smoking Cessation With Buproprion
Study design: Interventional, Treatment, Parallel Assignment
Primary outcome: Medication complianceSmoking Cessation
Eligibility
Minimum age: 18 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Exclusion Criteria:
- Pregnant or nursing women, or women of child-bearing potential who are not using an adequate method of contraception
- Psychiatric illnesses requiring psychotropic medications (i. e., psychosis, major depression, mania), or the presence of suicidality or homocidality
- Current use of nicotine replacement therapies (i. e., nicotine patch, gum, or lozenges, nasal spray, or inhaler), bupropion (Zyban, Wellbutrin), or marijuana or current participation in another smoking cessation treatment
- Presence of unstable medical conditions (i. e., cardiac, hepatic, renal disease, diabetes mellitus) that would make a trial of bupropion SR hazardous
- Have taken monoamine oxidase inhibitors or metoprolol succinate within the past six weeks
- History of anorexia nervosa or bulimia
- Previous hypersensitivity to bupropion
- History of alcohol or other drug dependence in the past one year
- History of seizure disorder of any etiology (i. e., brain tumor, traumatic brain injury, substance-induced seizures, etc.)
- Any finding that in the view of the principal investigator would compromise the subject's ability to fulfill the protocol visit schedule and visit requirements or put the subject at risk
- Sharing home or work environment with current or past participant
- No couples or participants who see each other every day
Locations and Contacts
Substance Abuse Treatment Unit, New Haven, Connecticut 06519, United States
Additional Information
Starting date:
September 2000
Last updated: November 3, 2005
|
